AKT1 and prostate carcinoma: Their research showed that palmitic acid may inhibit the tumor metastasis regulator protein in human prostate cancer cells by inhibiting the PI3K/Akt pathway to induce cell cycle G1 phase arrest and anti-metastatic efficiency [50].